Journals / Perinatoloji Dergisi / 2005 / Cilt: 13 - Sayı: 1

Comparison of treatment modalities of single dose and seven day courses in the treatment of the pregnant women with uncomplicated urinary tract infection or symptomatic pregnant women with $10^3$-$10^5$/ml mid-stream bacteriuria

Komplike olmamış alt üriner sistem enfeksiyonu bulunan ve orta idrarda $10^3$-$10^5$/ml bakteriürisi olan semptomatik gebelerde, tek doz ve yedi günlük tedavi yöntemlerinin karşılaştırılması

Pages
39–43
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: There was no difference between efficacy of single dose, intramuscular 2 g- cefoxitin and 7 day courses of oral amoxicillin (2 g/daily) therapy in the treatment of pregnants with uncomplicated lower urinary tract infection or symptomatic pregnant women with 103-105/ml midstream bacteriuria.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Comparison of bacteriologic efficacy of single dose, intramuscular 2 g-cefoxitin (Mefoxime®, Merck Sharp Dome) and 7 day courses of oral amoxicillin (2 g/ daily) (Largopen®, Bilim) in the treatment of the pregnant with uncomplicated urinary tract infection (Group 1) or symptomatic pregnant women with 10(3>-10(B)/ml mid-stream bacteriuria (Group 2).Methods: The pregnant women in the Group 1 and 2 between 6-34 (mean 20+1.61) gestation weeks were randomly selected for taking single dose, intramuscular 2 g-cefoxitin and 7 day courses of oral amoxicillin (2 g/ daily).
📊
Key Findings & Data:Twenty-five patients were in cefoxitin group and 23 were in amoxicillin group.
💡
Conclusion & Impact:Conclusion: There was no difference between efficacy of single dose, intramuscular 2 g- cefoxitin and 7 day courses of oral amoxicillin (2 g/daily) therapy in the treatment of pregnants with uncomplicated lower urinary tract infection or symptomatic pregnant women with 103-105/ml midstream bacteriuria.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Sefoksitin · İleriye dönük çalışma · İdrar

Abstract

Objective: Comparison of bacteriologic efficacy of single dose, intramuscular 2 g-cefoxitin (Mefoxime®, Merck Sharp Dome) and 7 day courses of oral amoxicillin (2 g/ daily) (Largopen®, Bilim) in the treatment of the pregnant with uncomplicated urinary tract infection (Group 1) or symptomatic pregnant women with 10(3>-10(B)/ml mid-stream bacteriuria (Group 2).Methods: The pregnant women in the Group 1 and 2 between 6-34 (mean 20+1.61) gestation weeks were randomly selected for taking single dose, intramuscular 2 g-cefoxitin and 7 day courses of oral amoxicillin (2 g/ daily). Twenty-five patients were in cefoxitin group and 23 were in amoxicillin group. There was no clinic difference according to demographic and patient character between the groups (p>0.05). The pathogens were identified by using of urine culture and repeat urine cultures were performed 10 days after initiation of therapy for bacteriologic evaluation of the patients. Results: Bacterial eradication rates were 16/20 (80%) after single dose, intramuscular 2 g- cefoxitin and 15/18 (83%) in 7 day courses of oral amoxicillin (2 g/ daily) in the Group 1. All pregnant women in the Group 2 were responded well to the treatment. There was no difference between single dose, intramuscular, 2g-cefoxitin and 7 day courses of oral amoxicillin (2 g/ daily) according to bacteriologic evaluation in the both groups (p>0.05). Although the sensitivity of cefoxitin and amoxicillin were 79% (15/19) and 94% (16/17) for E. coli, the most common pathogen, respectively, the difference was not statistically significant (p>0.05). Conclusion: There was no difference between efficacy of single dose, intramuscular 2 g- cefoxitin and 7 day courses of oral amoxicillin (2 g/daily) therapy in the treatment of pregnants with uncomplicated lower urinary tract infection or symptomatic pregnant women with 103-105/ml midstream bacteriuria.

Özet

Amaç: Komplike olmamış alt üriner sistem enfeksiyonu olan (Grup 1) ve üriner sistem enfeksiyon şikayetleri olup orta idrarda 10(3)-10(5)/ml bakteriürisi bulunan gebelerde (Grup 2) tek doz intramusküler 2 g-sefoksitin (Mefoxim®, Merck Sharp Dome) ile yedi günlük oral amoksisilin 2 g/ günlük (Largopen®, Bilim) tedavisinin bakteriyolojik etkinliklerinin karşılaştırılması. Yöntem: Grup 1 ve 2'de yer alan 6-34. haftalar arasındaki gebeler (ortalama gebelik haftası: 20.00±1.61), tek doz, intramusküler 2g-sefoksitin veya yedi günlük, oral, 2 g-amoksisilin almak için randomize edildi. Yirmibeş hasta sefoksitin, 23 hasta amoksisilin grubunda yer aldı. Çalışmaya alınan gruplar arasında demografik ve hasta karakterleri bakımından klinik farklılık yoktu (p>0.05). Patojenlerin tanımlanması idrar kültürü ile yapıldı ve tedavi başlangıcından 10 gün sonra hastalar bakteriyolojik değerlendirme için tekrar idrar kültürü ile değerlendirildi. Bulgular: Grup 1 için, tek doz, intramusküler 2g-sefoksitin sonrası bakteriyel eradikasyon oranı 16/20 (%80), yedi günlük, oral, 2 g-amoksisilin sonrası ise 15/18 (%83) idi. Grup 2'de yer alan olguların tümü tedaviye yanıt verdi. Tedaviden sonra uygulanan bakteriyolojik değerlendirme sonucunda, Grup 1 ve 2'de yer alan gebelerin tedavi etkinlikleri arasında fark yoktu (p>0.05). En sık tespit edilen patojen olan Escherichia coli'ye olan duyarlılık, sefoksitin tedavisi alan gebelerde %79, amoksisilin tedavisi alan gebelerde ise %94 olarak gözlenmesine rağmen istatistiksel olarak anlamlı değildi (p>0.05). Sonuç: Akut komplike olmamış alt üriner sistem enfeksiyonu veya üriner sistem enfeksiyon şikayetleri olup orta idrarda 10(3)-10(5)/ml bakteriürisi bulunan gebelerde uygulanan tek doz, intramusküler, 2 g-sefoksitin ile yedi günlük, oral, 2 g-amoksisilin tedavilerinin etkinlikleri arasında fark gözlenmedi.

🔖

Cite This Article

GÜVEN, M. A., ÇIRAGİL, P., ŞAHİNKANAT, T., ÖZDEMİR, Ö., KÖSTÜ, B., ERCAN, Ö. (2005). Comparison of treatment modalities of single dose and seven day courses in the treatment of the pregnant women with uncomplicated urinary tract infection or symptomatic pregnant women with $10^3$-$10^5$/ml mid-stream bacteriuria. Perinatoloji Dergisi, Cilt: 13 - Sayı: 1, 39–43. https://ajindex.com/articles/300361

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. MacLean AB. Urinary tract infection and pregnancy. In: Cattell WR, editor. Infections of the Kidney and Urinary Tract. Oxford: Oxford University Press, 1996
  2. MacLean AB. Urinary tract infection and pregnancy. Int J Antimicrob Agents 2001; 17: 273-7
  3. Rubin RH, Beam TR, Stamm WE. An approach to evaluating antibacterial agents in the treatment of urinary tract infection. Clin Inf Dis 1992; 14: 246-51
  4. Stamm WE, Counts GW, Running KR, Fihn S, Turck M, Holmes KK. Diagnosis of coliform infection in acutely dysuric women. N Engl J Med 1982; 307: 463-8
  5. Kutlay S, Kutlay B, Karaahmetoğlu O, Ak C, Erkaya S. Prevalance, detection and treatment of symptomathic bacteriuria in a Turkish obstetric population. J Reprod Med 2003; 8: 627-30
  6. Minassian MA, Lewis DA, Chattopadhyay D, Bovill B, Duckworth GJ, Williams JD. A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women. Int J Antimicrob Agents 1998; 10: 39-47
  7. Ronald A, Nicolle LE, Harding G. Single dose treatment failure in women with acute cystitis. Infection 1992; 20: 276-9
  8. Hatton J, Hughes M, Raymond CH. Management of bacterial urinary tract infections in adults. Ann Pharmacother 1994; 28: 1264-72
  9. Naber KG. Uncomplicated urinary tract infections- is single dose therapy effective? Int J Antimicrob Agents 1994; 4: 39-45
  10. Stamm WE. Contraversies in single dose therapy of acute uncomplicated urinary tract infections in women. Infection 1992; 20: 272-5
  11. Norrby SR. Short term treatment of uncomplicated lower urinary tract infections in adult women women- an overview. Rev Infect Dis 1990; 12: 458-67. • McFadyen IR, Campbell-Brown M, Stephenson M, Seal DV. Single-dose treatment of bacteriuria in pregnancy. Eur Urol 1987; 13: 22-5.